Work for Sol-Gel Technologies Ltd.?

Claim Your Profile

Sol-Gel Technologies Ltd. Logo Image

Sol-Gel Technologies Ltd.

About Sol-Gel Technologies Ltd.

11-50 Employees
Based in Ness Ziona, Israel

Sol-Gel is a clinical-stage specialty pharmaceutical company focused on developing and commercializing topical dermatological drug products. Their lead product candidates, VERED for the treatment of papulopustular rosacea and TWIN and SIRS-T for the treatment of acne vulgaris (“acne”) are based upon their proprietary microencapsulation delivery system. This technology consists of microcapsules made of silica. Based on their pre-clinical and clinical data, this delivery system should enable them to develop and commercialize dermatological drug products that are more effective and/or have fewer side effects than currently marketed drugs.

Ticker:
SLGL
Exchange:
NASDAQ (See More NASDAQ Companies)
Industry:
Biotechnology (See More Biotechnology Companies)
Sector:
Healthcare (See More Healthcare Companies)

Looking for Other Annual Reports?

Search by company name or ticker symbol